Evidence map›Paper›PMID 40226413›Full record

ArticleJournal of tissue engineering and regenerative medicine2023

Ascorbic Acid 2-Phosphate-Releasing Supercritical Carbon Dioxide-Foamed Poly(L-Lactide-Co-epsilon-Caprolactone) Scaffolds Support Urothelial Cell Growth and Enhance Human Adipose-Derived Stromal Cell Proliferation and Collagen Production.

Alma Kurki, Kaarlo Paakinaho, Markus Hannula, Jari Hyttinen, Susanna Miettinen, Reetta Sartoneva

Abstract read
In one paragraph

Article in Journal of tissue engineering and regenerative medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. COGels (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alma KurkiFaculty of Medicine and Health Technology (MET), Tampere University, Tampere, Finland.ORCID 0000-0001-7978-6293
Kaarlo PaakinahoFaculty of Medicine and Health Technology (MET), Tampere University, Tampere, Finland.
Markus HannulaFaculty of Medicine and Health Technology (MET), Tampere University, Tampere, Finland.ORCID 0000-0002-4485-8004
Jari HyttinenFaculty of Medicine and Health Technology (MET), Tampere University, Tampere, Finland.ORCID 0000-0003-1850-3055
Susanna MiettinenFaculty of Medicine and Health Technology (MET), Tampere University, Tampere, Finland.ORCID 0000-0002-0647-9556
Reetta SartonevaFaculty of Medicine and Health Technology (MET), Tampere University, Tampere, Finland.ORCID 0000-0001-5492-571X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue engineering can provide a novel approach for the reconstruction of large urethral defects, which currently lacks optimal repair methods. Cell-seeded scaffolds aim to prevent urethral stricture and scarring, as effective urothelium and stromal tissue regeneration is important in urethral repair. In this study, the aim was to evaluate the effect of the novel porous ascorbic acid 2-phosphate (A2P)-releasing supercritical carbon dioxide-foamed poly(L-lactide-co-

Indexed as

Adipose TissueCarbon DioxideCollagenPolyestersStromal CellsTissue ScaffoldsUrotheliumAscorbic AcidCell ProliferationCell SurvivalCoculture TechniquesHumansTissue Engineeringascorbate-2-phosphateAscorbic AcidCarbon DioxideCollagenPolyesterspoly(lactic acid-co-epsilon-caprolactone)

Identifiers

PMID40226413
PMCPMC11919108

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.